ImageneBio (IMA) Return on Sales [ROS] (2020 - 2025)
ImageneBio (IMA) posted Return on Sales [ROS] of -1582.84% for Q3 2025, down 1524.67 percentage points from -58.17% a year earlier and down 705.56 percentage points from the prior quarter.
Powered by 
Analysis
ImageneBio (IMA) Return on Sales [ROS] (2020 - 2025) Analysis & Trends
For FY2023, ImageneBio's Return on Sales [ROS] came in at -823.33%, down 369.34 percentage points from FY2022.
- Annual Return on Sales [ROS] shows a three-year change of -339.11 percentage points (FY2020 to FY2023).
- In prior years, ImageneBio's Return on Sales [ROS] was -453.99% in FY2022 (-343.81 pp), -110.18% in FY2021 (+374.04 pp) and -484.22% in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Return on Sales [ROS] since Q4 2023.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2021, with a gain of 40095.35 percentage points; the weakest was Q2 2022, with a drop of 5127.07 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 28.37% |
| 10 | ImageneBio | 34.53 Mn | -453.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,582.84% |
| Jun 30, 2025 | -877.27% |
| Mar 31, 2025 | -749.38% |
| Sep 30, 2024 | -58.17% |
| Dec 31, 2023 | -3,324.43% |
| Sep 30, 2023 | -1,645.82% |
| Jun 30, 2023 | -922.65% |
| Mar 31, 2023 | -292.02% |
| Dec 31, 2022 | -277.32% |
| Sep 30, 2022 | -279.23% |
| Jun 30, 2022 | -5,484.55% |
| Mar 31, 2022 | -501.24% |
| Dec 31, 2021 | 13.81% |
| Sep 30, 2021 | -387.67% |
| Jun 30, 2021 | -357.48% |
| Mar 31, 2021 | -279.79% |
| Dec 31, 2020 | -40,081.54% |
| Sep 30, 2020 | -220.33% |
| Jun 30, 2020 | -164.63% |
| Mar 31, 2020 | -222.37% |
API Access
ImageneBio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();